Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report

AbstractIntroduction Bupropion overdose can produce seizures, arrhythmias, and shock. The toxicokinetics of massive bupropion ingestions are not well characterized.Case report A 22-year-old female ingested an estimated 40.5 g (644 mg/kg) of extended release bupropion. Subsequently she experienced se...

Full description

Bibliographic Details
Main Authors: Michael E. O’Brien, Michael Chary, Philicia Moonsamy, Michele M. Burns, Andrew Tom, Gaston Cudemus
Format: Article
Language:English
Published: Taylor & Francis Group 2021-11-01
Series:Toxicology Communications
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/24734306.2021.1903725
_version_ 1797300158091755520
author Michael E. O’Brien
Michael Chary
Philicia Moonsamy
Michele M. Burns
Andrew Tom
Gaston Cudemus
author_facet Michael E. O’Brien
Michael Chary
Philicia Moonsamy
Michele M. Burns
Andrew Tom
Gaston Cudemus
author_sort Michael E. O’Brien
collection DOAJ
description AbstractIntroduction Bupropion overdose can produce seizures, arrhythmias, and shock. The toxicokinetics of massive bupropion ingestions are not well characterized.Case report A 22-year-old female ingested an estimated 40.5 g (644 mg/kg) of extended release bupropion. Subsequently she experienced seizures, required intubation, developed torsades des pointes that progressed to cardiac arrest, and required cannulation with venous-arterial extracorporeal membrane oxygenation (VA-ECMO). Intravenous lipid emulsion was administered without adversely affecting the ECMO circuit. The patient was successfully decannulated after 84 h of ECMO support and discharged neurologically intact. Serial bupropion and hydroxybupropion serum concentrations were drawn every 6-12 h starting on hospital day one and continuing for seven days, for a total of 22 serum concentrations each.Discussion The patient’s first bupropion and hydroxybupropion serum concentrations were 4000 ng/mL and 5300 ng/mL, respectively. Clearance of bupropion followed first order kinetics (t ½ = 20.6 h) while hydroxybupropion had zero order kinetics (t ½ = 118.5 h).Conclusion This bupropion overdose was treated with VA-ECMO with 20% lipid emulsion therapy, without complications. In this patient, the toxicokinetics of bupropion were first-order.
first_indexed 2024-03-07T23:03:12Z
format Article
id doaj.art-788ad2a9ae4f4cc99db09640eb5a7131
institution Directory Open Access Journal
issn 2473-4306
language English
last_indexed 2024-03-07T23:03:12Z
publishDate 2021-11-01
publisher Taylor & Francis Group
record_format Article
series Toxicology Communications
spelling doaj.art-788ad2a9ae4f4cc99db09640eb5a71312024-02-22T09:16:09ZengTaylor & Francis GroupToxicology Communications2473-43062021-11-0151858710.1080/24734306.2021.1903725Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case reportMichael E. O’Brien0Michael Chary1Philicia Moonsamy2Michele M. Burns3Andrew Tom4Gaston Cudemus5Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USARegional Center for Poison Control and Prevention, Boston, MA, USADivision of Cardiac Surgery, Massachusetts General Hospital, Boston, MA, USARegional Center for Poison Control and Prevention, Boston, MA, USADepartment of Pharmacy, Massachusetts General Hospital, Boston, MA, USADivision of Cardiac Anesthesiology, Massachusetts General Hospital Harvard Medical School, Boston, MA, USAAbstractIntroduction Bupropion overdose can produce seizures, arrhythmias, and shock. The toxicokinetics of massive bupropion ingestions are not well characterized.Case report A 22-year-old female ingested an estimated 40.5 g (644 mg/kg) of extended release bupropion. Subsequently she experienced seizures, required intubation, developed torsades des pointes that progressed to cardiac arrest, and required cannulation with venous-arterial extracorporeal membrane oxygenation (VA-ECMO). Intravenous lipid emulsion was administered without adversely affecting the ECMO circuit. The patient was successfully decannulated after 84 h of ECMO support and discharged neurologically intact. Serial bupropion and hydroxybupropion serum concentrations were drawn every 6-12 h starting on hospital day one and continuing for seven days, for a total of 22 serum concentrations each.Discussion The patient’s first bupropion and hydroxybupropion serum concentrations were 4000 ng/mL and 5300 ng/mL, respectively. Clearance of bupropion followed first order kinetics (t ½ = 20.6 h) while hydroxybupropion had zero order kinetics (t ½ = 118.5 h).Conclusion This bupropion overdose was treated with VA-ECMO with 20% lipid emulsion therapy, without complications. In this patient, the toxicokinetics of bupropion were first-order.https://www.tandfonline.com/doi/10.1080/24734306.2021.1903725BupropionECMOlipid emulsionpharmacokineticscase report
spellingShingle Michael E. O’Brien
Michael Chary
Philicia Moonsamy
Michele M. Burns
Andrew Tom
Gaston Cudemus
Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
Toxicology Communications
Bupropion
ECMO
lipid emulsion
pharmacokinetics
case report
title Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
title_full Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
title_fullStr Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
title_full_unstemmed Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
title_short Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
title_sort successful use of ecmo and lipid emulsion for massive bupropion overdose a case report
topic Bupropion
ECMO
lipid emulsion
pharmacokinetics
case report
url https://www.tandfonline.com/doi/10.1080/24734306.2021.1903725
work_keys_str_mv AT michaeleobrien successfuluseofecmoandlipidemulsionformassivebupropionoverdoseacasereport
AT michaelchary successfuluseofecmoandlipidemulsionformassivebupropionoverdoseacasereport
AT philiciamoonsamy successfuluseofecmoandlipidemulsionformassivebupropionoverdoseacasereport
AT michelemburns successfuluseofecmoandlipidemulsionformassivebupropionoverdoseacasereport
AT andrewtom successfuluseofecmoandlipidemulsionformassivebupropionoverdoseacasereport
AT gastoncudemus successfuluseofecmoandlipidemulsionformassivebupropionoverdoseacasereport